Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
6 studies found for:    Open Studies | "Tinea Pedis"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting SB208 for the Treatment of Tinea Pedis
Condition: Tinea Pedis
Interventions: Drug: SB208 2%;   Drug: SB208 4%;   Drug: SB208 16%;   Drug: Vehicle Gel
2 Not yet recruiting Efficacy and Safety of Product S2G6T-1in Patients With Symptomatic Inflammatory Interdigital Tinea Pedis
Condition: Tinea Pedis
Interventions: Drug: S2G6T-1;   Drug: S2G6T-2;   Drug: S2G6T-3;   Drug: S2G6T-4
3 Not yet recruiting Non-inferiority Phase III Trial Comparing Dapaconazole Cream 2% With Ketoconazole Cream 2% in Patients With Tinea Pedis
Condition: Tinea Pedis
Interventions: Drug: Dapaconazole;   Drug: Ketoconazole
4 Recruiting Nitric Oxide Releasing Solution (NORS) Footbath to Treat Athlete's Foot
Condition: Tinea Pedis
Interventions: Drug: Nitric Oxide;   Drug: Water
5 Recruiting Glucosamine Sulphate and Ginkgo Biloba as Antifungal Activity for Treating Tinea Pedis
Condition: Foot Infection Tinea Pedis
Interventions: Drug: infected group;   Drug: control group
6 Recruiting Study Evaluating the Drug Interaction Potential of Luliconazole Cream 1% in Subjects With Tinea Pedis and Tinea Cruris
Conditions: Tinea Pedis;   Tinea Cruris
Intervention: Drug: Omeprazole 40mg

Study has passed its completion date and status has not been verified in more than two years.